Broadway Wealth Solutions Inc. Trims Stake in Oracle Corporation $ORCL

Broadway Wealth Solutions Inc. decreased its position in shares of Oracle Corporation (NYSE:ORCL) by 5.5% during the second quarter, Holdings Channel reports. The fund owned 1,586 shares of the enterprise software provider’s stock after selling 93 shares during the period. Broadway Wealth Solutions Inc.’s holdings in Oracle were worth $347,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Harel Insurance Investments & Financial Services Ltd. boosted its stake in shares of Oracle by 71.6% in the 1st quarter. Harel Insurance Investments & Financial Services Ltd. now owns 257,378 shares of the enterprise software provider’s stock worth $35,984,000 after buying an additional 107,404 shares during the last quarter. Lockheed Martin Investment Management Co. raised its holdings in Oracle by 4.3% during the first quarter. Lockheed Martin Investment Management Co. now owns 51,350 shares of the enterprise software provider’s stock valued at $7,179,000 after acquiring an additional 2,110 shares during the period. Lockerman Financial Group Inc. bought a new stake in Oracle during the second quarter valued at about $328,000. Elser Financial Planning Inc bought a new stake in Oracle during the second quarter valued at about $1,066,000. Finally, Canoe Financial LP increased its holdings in shares of Oracle by 314.8% in the second quarter. Canoe Financial LP now owns 484,098 shares of the enterprise software provider’s stock worth $105,838,000 after purchasing an additional 367,400 shares during the last quarter. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on ORCL shares. Berenberg Bank lifted their target price on Oracle from $202.00 to $306.00 and gave the stock a “hold” rating in a report on Monday, September 15th. Morgan Stanley boosted their target price on Oracle from $246.00 to $320.00 and gave the company an “equal weight” rating in a research report on Tuesday, September 23rd. Oppenheimer reiterated an “outperform” rating on shares of Oracle in a report on Wednesday, June 18th. JPMorgan Chase & Co. boosted their price objective on shares of Oracle from $185.00 to $210.00 and gave the stock a “neutral” rating in a research note on Monday, September 8th. Finally, Roth Capital reissued a “hold” rating on shares of Oracle in a research note on Wednesday, June 18th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have issued a Buy rating, nine have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $304.71.

Insider Transactions at Oracle

In related news, Director Naomi O. Seligman sold 3,303 shares of the firm’s stock in a transaction dated Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total value of $770,655.96. Following the transaction, the director directly owned 31,447 shares of the company’s stock, valued at approximately $7,337,214.04. This trade represents a 9.51% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the firm’s stock in a transaction dated Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider directly owned 132,656 shares in the company, valued at $42,603,800.96. This represents a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 114,314 shares of company stock worth $33,602,123 in the last three months. 42.20% of the stock is owned by corporate insiders.

Oracle Trading Down 0.6%

ORCL stock opened at $281.01 on Wednesday. The company’s 50-day simple moving average is $259.82 and its 200-day simple moving average is $202.64. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. Oracle Corporation has a 52-week low of $118.86 and a 52-week high of $345.72. The firm has a market cap of $801.10 billion, a P/E ratio of 65.05, a PEG ratio of 3.04 and a beta of 1.46.

Oracle (NYSE:ORCL) last posted its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The firm had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. During the same period in the previous year, the company earned $1.39 earnings per share. The company’s revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, equities analysts forecast that Oracle Corporation will post 5 EPS for the current fiscal year.

Oracle Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle’s dividend payout ratio is presently 46.30%.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.